Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Morepen Laboratories has informed that it attached letter dated 10th July 2023, received from Registrar and Share Transfer Agent of the company (MAS Services), comprising information related to issuance of letter(s) of confirmation against duplicate share certificates in electronic mode, in compliance with SEBI Circular No. SEBI/HO/MIRSD/ MIRSD_RTAMB/P/CIR/2022/8 dated 25th January 2022.
The above information is a part of company’s filings submitted to BSE.
